Clara Campàs

Biography

 Clara is the director of Strategy & Development at Kern Pharma sl, were she coordinates the departments of R&D, innovation, business development and regulatory affairs. Formerly, she worked at Advancell, SA as Managing Director and Drug development Director, as well as a Researcher at Hospital del Mar. She is the co-author of the patent Acadesine, the first drug originated in a Spanish public University that successfully reached clinical trials. She is member of the investors committee of the venture capital fund HealthEquity, VicePresident of CataloniaBIO and member of the board of trustees of Biocat. Clara Campàs-Moya holds a PhD in Pharmacy by the Universitat de Barcelona.

Research Interest

 General Science